Cargando…

A validation of presepsin levels in kidney dysfunction patients: four case reports

Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotera, Atsushi, Sagishima, Katsuyuki, Tashiro, Takahiro, Niimori, Daisuke, Kamohara, Hidenobu, Kinoshita, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336244/
https://www.ncbi.nlm.nih.gov/pubmed/25705419
http://dx.doi.org/10.1186/s40560-014-0063-2
_version_ 1782358437706858496
author Kotera, Atsushi
Sagishima, Katsuyuki
Tashiro, Takahiro
Niimori, Daisuke
Kamohara, Hidenobu
Kinoshita, Yoshihiro
author_facet Kotera, Atsushi
Sagishima, Katsuyuki
Tashiro, Takahiro
Niimori, Daisuke
Kamohara, Hidenobu
Kinoshita, Yoshihiro
author_sort Kotera, Atsushi
collection PubMed
description Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergone resection for rectal cancer and ileal conduit replacement. On day 1 in the ICU, Escherichia coli (E. coli) was isolated by urine culture. PSP level (pg/ml) on day 2 was 2,745 without elevation of other conventional biomarkers. On day 6, the patient was diagnosed with severe sepsis, and E. coli was isolated by blood culture. By then, PSP had risen to 3,977, along with elevation of other conventional biomarkers. His kidney function recovered gradually after continuous administration of hemodiafiltration; however, PSP continued to rise up to 6,051, along with high systemic inflammatory response syndrome (SIRS) and Acute Physiology and Chronic Health Evaluation (APACHE) II values. The patient expired on day 13 due to multiple organ failure. Case 2: a 78-year-old woman with CKD on hemodialysis (HD) was admitted to the ICU after cardiovascular surgery. Continuous HD was administered postoperatively, and PSP ranged from 1,473–1,870 without signs of sepsis. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 3: a 74-year-old woman with CKD on HD was admitted to the ICU after neurosurgery. She underwent intermittent HD postoperatively, and PSP ranged from 1,240–1,935 without sepsis symptoms. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 4: a 62-year-old man with CKD was admitted to the ICU to control gastrointestinal bleeding. PSP was 606 without signs of infection or elevation of other conventional biomarkers. In cases 2, 3, and 4, bacteria were not isolated in blood cultures. Patients’ clinical prognoses were good, with low or moderate SIRS and APACHE II scores. PSP in kidney dysfunction patients will be high despite non-infectious conditions. Therefore, evaluation of PSP in kidney dysfunction patients will be difficult. Further investigation is needed to clarify the relationship between PSP and kidney dysfunction.
format Online
Article
Text
id pubmed-4336244
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43362442015-02-22 A validation of presepsin levels in kidney dysfunction patients: four case reports Kotera, Atsushi Sagishima, Katsuyuki Tashiro, Takahiro Niimori, Daisuke Kamohara, Hidenobu Kinoshita, Yoshihiro J Intensive Care Letter to the Editor Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergone resection for rectal cancer and ileal conduit replacement. On day 1 in the ICU, Escherichia coli (E. coli) was isolated by urine culture. PSP level (pg/ml) on day 2 was 2,745 without elevation of other conventional biomarkers. On day 6, the patient was diagnosed with severe sepsis, and E. coli was isolated by blood culture. By then, PSP had risen to 3,977, along with elevation of other conventional biomarkers. His kidney function recovered gradually after continuous administration of hemodiafiltration; however, PSP continued to rise up to 6,051, along with high systemic inflammatory response syndrome (SIRS) and Acute Physiology and Chronic Health Evaluation (APACHE) II values. The patient expired on day 13 due to multiple organ failure. Case 2: a 78-year-old woman with CKD on hemodialysis (HD) was admitted to the ICU after cardiovascular surgery. Continuous HD was administered postoperatively, and PSP ranged from 1,473–1,870 without signs of sepsis. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 3: a 74-year-old woman with CKD on HD was admitted to the ICU after neurosurgery. She underwent intermittent HD postoperatively, and PSP ranged from 1,240–1,935 without sepsis symptoms. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 4: a 62-year-old man with CKD was admitted to the ICU to control gastrointestinal bleeding. PSP was 606 without signs of infection or elevation of other conventional biomarkers. In cases 2, 3, and 4, bacteria were not isolated in blood cultures. Patients’ clinical prognoses were good, with low or moderate SIRS and APACHE II scores. PSP in kidney dysfunction patients will be high despite non-infectious conditions. Therefore, evaluation of PSP in kidney dysfunction patients will be difficult. Further investigation is needed to clarify the relationship between PSP and kidney dysfunction. BioMed Central 2014-12-03 /pmc/articles/PMC4336244/ /pubmed/25705419 http://dx.doi.org/10.1186/s40560-014-0063-2 Text en © Atsushi et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Kotera, Atsushi
Sagishima, Katsuyuki
Tashiro, Takahiro
Niimori, Daisuke
Kamohara, Hidenobu
Kinoshita, Yoshihiro
A validation of presepsin levels in kidney dysfunction patients: four case reports
title A validation of presepsin levels in kidney dysfunction patients: four case reports
title_full A validation of presepsin levels in kidney dysfunction patients: four case reports
title_fullStr A validation of presepsin levels in kidney dysfunction patients: four case reports
title_full_unstemmed A validation of presepsin levels in kidney dysfunction patients: four case reports
title_short A validation of presepsin levels in kidney dysfunction patients: four case reports
title_sort validation of presepsin levels in kidney dysfunction patients: four case reports
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336244/
https://www.ncbi.nlm.nih.gov/pubmed/25705419
http://dx.doi.org/10.1186/s40560-014-0063-2
work_keys_str_mv AT koteraatsushi avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT sagishimakatsuyuki avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT tashirotakahiro avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT niimoridaisuke avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT kamoharahidenobu avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT kinoshitayoshihiro avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT koteraatsushi validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT sagishimakatsuyuki validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT tashirotakahiro validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT niimoridaisuke validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT kamoharahidenobu validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports
AT kinoshitayoshihiro validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports